155 related articles for article (PubMed ID: 38782795)
1. The impact of different anticoagulants and antiplatelets regimens on acute epistaxis outcomes.
Zloczower E; Pinhas S; Allon R; Syn-Hershko A; Raz Yarkoni T; Marom M; Kiderman D; Cohen O; Warman M
Eur Arch Otorhinolaryngol; 2024 May; ():. PubMed ID: 38782795
[TBL] [Abstract][Full Text] [Related]
2. Clinical Practice Guideline: Nosebleed (Epistaxis).
Tunkel DE; Anne S; Payne SC; Ishman SL; Rosenfeld RM; Abramson PJ; Alikhaani JD; Benoit MM; Bercovitz RS; Brown MD; Chernobilsky B; Feldstein DA; Hackell JM; Holbrook EH; Holdsworth SM; Lin KW; Lind MM; Poetker DM; Riley CA; Schneider JS; Seidman MD; Vadlamudi V; Valdez TA; Nnacheta LC; Monjur TM
Otolaryngol Head Neck Surg; 2020 Jan; 162(1_suppl):S1-S38. PubMed ID: 31910111
[TBL] [Abstract][Full Text] [Related]
3. Clinical Practice Guideline: Nosebleed (Epistaxis) Executive Summary.
Tunkel DE; Anne S; Payne SC; Ishman SL; Rosenfeld RM; Abramson PJ; Alikhaani JD; Benoit MM; Bercovitz RS; Brown MD; Chernobilsky B; Feldstein DA; Hackell JM; Holbrook EH; Holdsworth SM; Lin KW; Lind MM; Poetker DM; Riley CA; Schneider JS; Seidman MD; Vadlamudi V; Valdez TA; Nnacheta LC; Monjur TM
Otolaryngol Head Neck Surg; 2020 Jan; 162(1):8-25. PubMed ID: 31910122
[TBL] [Abstract][Full Text] [Related]
4. The Impact of Traditional Anticoagulants, Novel Anticoagulants, and Antiplatelets on Epistaxis.
Yaniv D; Zavdy O; Sapir E; Levi L; Soudry E
Laryngoscope; 2021 Sep; 131(9):1946-1951. PubMed ID: 33533493
[TBL] [Abstract][Full Text] [Related]
5. Non-Vitamin K Oral Anticoagulants (NOAC) Versus Vitamin K Antagonists (VKA) for Atrial Fibrillation with Elective or Urgent Percutaneous Coronary Intervention: A Meta-Analysis with a Particular Focus on Combination Type.
Eyileten C; Postula M; Jakubik D; Toma A; Mirowska-Guzel D; Patti G; Renda G; Siller-Matula JM
J Clin Med; 2020 Apr; 9(4):. PubMed ID: 32295160
[TBL] [Abstract][Full Text] [Related]
6. Comparison of early clinical outcomes between dual antiplatelet therapy and triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention.
Park J; Jung JH; Choi EK; Lee SW; Kwon S; Lee SR; Kang J; Han KD; Park KW; Oh S; Lip GYH
PLoS One; 2022; 17(2):e0264538. PubMed ID: 35213632
[TBL] [Abstract][Full Text] [Related]
7. Vitamin K antagonists but not non-vitamin K antagonists in addition on antiplatelet therapy should be associated with increase of hematoma volume and mortality in patients with intracerebral hemorrhage: A sub-analysis of PASTA registry study.
Nomura K; Suda S; Abe A; Iguchi Y; Yagita Y; Kanzawa T; Okubo S; Fujimoto S; Kimura K;
J Neurol Sci; 2023 May; 448():120643. PubMed ID: 37028263
[TBL] [Abstract][Full Text] [Related]
8. Clinical Characteristics And Health Care Resources In Patients Treated With Oral Anticoagulants: Evidences From Italian Administrative Databases.
Degli Esposti L; Andretta M; Di Pasquale G; Gambera M; Saragoni S; Perrone V; Buda S
Vasc Health Risk Manag; 2019; 15():429-437. PubMed ID: 31632047
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of novel oral anticoagulants in patients with cervical artery dissections.
Caprio FZ; Bernstein RA; Alberts MJ; Curran Y; Bergman D; Korutz AW; Syed F; Ansari SA; Prabhakaran S
Cerebrovasc Dis; 2014; 38(4):247-53. PubMed ID: 25401389
[TBL] [Abstract][Full Text] [Related]
10. Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome.
Bala MM; Celinska-Lowenhoff M; Szot W; Padjas A; Kaczmarczyk M; Swierz MJ; Undas A
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD012169. PubMed ID: 33045766
[TBL] [Abstract][Full Text] [Related]
11. Shifting from vitamin K antagonists to non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: predictors, patterns and temporal trends.
Shiyovich A; Shalev V; Chodick G; Tirosh M; Katz A; Klar MM; Shuvy M; Pereg D; Minha S
BMC Cardiovasc Disord; 2021 Oct; 21(1):493. PubMed ID: 34645389
[TBL] [Abstract][Full Text] [Related]
12. Epistaxis complicating treatment by anti-vitamin K and new oral anticoagulants.
L'Huillier V; Badet C; Tavernier L
Eur Ann Otorhinolaryngol Head Neck Dis; 2018 Aug; 135(4):231-235. PubMed ID: 29735286
[TBL] [Abstract][Full Text] [Related]
13. Antithrombotic strategies in patients needing oral anticoagulation undergoing percutaneous coronary intervention: A network meta-analysis.
Saglietto A; D'Ascenzo F; Errigo D; Leonardi S; Dewilde WJ; Conrotto F; Omedè P; Montefusco A; Angelini F; De Filippo O; Bianco M; Gallone G; Bruno F; Zaccaro L; Giannini F; Latib A; Colombo A; Costa F; De Ferrari GM
Catheter Cardiovasc Interv; 2021 Mar; 97(4):581-588. PubMed ID: 32790145
[TBL] [Abstract][Full Text] [Related]
14. Effect of postoperative antithrombotic therapy on lower extremity outcomes after infrapopliteal bypass for chronic limb-threatening ischemia.
Marcaccio CL; Patel PB; Wang S; Rastogi V; Moreira CC; Siracuse JJ; Schermerhorn ML; Stangenberg L
J Vasc Surg; 2022 May; 75(5):1696-1706.e4. PubMed ID: 35074410
[TBL] [Abstract][Full Text] [Related]
15. Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome.
Bala MM; Celinska-Lowenhoff M; Szot W; Padjas A; Kaczmarczyk M; Swierz MJ; Undas A
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012169. PubMed ID: 28968483
[TBL] [Abstract][Full Text] [Related]
16. Management and outcome of gastrointestinal bleeding in patients taking oral anticoagulants or antiplatelet drugs.
Pannach S; Goetze J; Marten S; Schreier T; Tittl L; Beyer-Westendorf J
J Gastroenterol; 2017 Dec; 52(12):1211-1220. PubMed ID: 28210867
[TBL] [Abstract][Full Text] [Related]
17. Safety and Efficacy of Antithrombotic Strategies in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Network Meta-analysis of Randomized Controlled Trials.
Lopes RD; Hong H; Harskamp RE; Bhatt DL; Mehran R; Cannon CP; Granger CB; Verheugt FWA; Li J; Ten Berg JM; Sarafoff N; Gibson CM; Alexander JH
JAMA Cardiol; 2019 Aug; 4(8):747-755. PubMed ID: 31215979
[TBL] [Abstract][Full Text] [Related]
18. Risk factors and management outcomes in epistaxis: a tertiary centre experience.
; ; . PubMed ID: 36539988
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
